This latest development of Medicare approval in the U.S. for its new SomnoDent Herbst Advance devices will drive further sales as the cost to the end consumer is significantly reduced or eliminated.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $163.6M | |||
| Open | High | Low | Value | Volume |
| 75.0¢ | 75.0¢ | 73.5¢ | $37.09K | 50.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14661 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 101723 | 2 |
View Market Depth
| Last trade - 15.56pm 10/09/2025 (20 minute delay) ? |
| SOM (ASX) Chart |